APUS
Apimeds Pharmaceuticals US Inc.

306
Mkt Cap
$20.37M
Volume
19,169.00
52W High
$4.03
52W Low
$1.37
PE Ratio
-3.76
APUS Fundamentals
Price
$1.56
Prev Close
$1.62
Open
$1.65
50D MA
$1.88
Beta
1.57
Avg. Volume
148,874.55
EPS (Annual)
-$0.1188
P/B
2.50
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
Apimeds Pharmaceuticals says I love my Ducks with new ai Futures Lab Program collaboration with the University of Oregons Lundquist College of Business
Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) (Apimeds) today announced the expansion of the Apimeds ai Futures Lab program through a new collaboration with the University of Oregons Lundquist...
Business Wire·4mo ago
<
...
1
>

Latest APUS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.